Analyst raised price objective for Elemental Altus Royalties stock.
2 reports, 1 independent
Updated Wed 00:00
No new developments lately
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Analyst raised price objective for Elemental Altus Royalties stock.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Raymond James Financial
American Investment Bank and Financial Services Firm
Related events
- Morgan Stanley and Raymond James Financial raised their price objectives for Elevance Health, Inc. on September 15, 2026.
- Analysts from Raymond James Financial, Desjardins, and Royal Bank of Canada increased price targets and ratings for Exchange Income Co.
- Analyst firms dropped price objectives and insider trading disclosures were filed with the SEC.
- Analysts have raised price targets and ratings for Elevance Health, involving Bank of America, Raymond James Financial, and TD Cowen.
- Analyst firm restated rating and target price for CeriBell on September 10, 2026.